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Nicastrin is a type I transmembrane glycoprotein, which is
part of the high molecular weight g-secretase complex. g-
Secretase is one of the key players associated with the gen-
eration of Alzheimer’s disease pathology, since it liberates
the neurotoxic amyloid b-peptide. Four proteins Nicastrin,
anterior pharynx-defective-1 (Aph-1), presenilin enhancer-2
(Pen-2) and Presenilin are essential to form the active g-
secretase complex. Recently it has been shown, that Nicastrin
has a key function in stabilizing the mature g-secretase com-
plex and may also be involved in substrate recognition. So
far no structural data for the Nicastrin ectodomain or any
other g-secretase component are available. We therefore used
Circular Dichroism (CD) spectroscopy to demonstrate that
Nicastrin, similar to its homologues, the Streptomyces
griseus aminopeptidase (SGAP) and the transferrin receptor
(TfR), adopts a thermostable secondary structure. Further-
more, the Nicastrin ectodomain has an exceptionally high
propensity to refold after thermal denaturation. These find-
ings provide evidence to further support the hypothesis that
Nicastrin may share evolutionary conserved properties with
the aminopeptidase and the transferrin receptor family.
Keywords: Ab-peptide; Alzheimer’s disease; g-secretase;
Presenilin; regulated intramembrane proteolysis (RIP);
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Introduction
Nicastrin is a 709 amino acid type I transmembrane glyco-
protein, which is known to be an essential component of the
g-secretase complex (Yu et al., 2000; Edbauer et al., 2002;
Leem et al., 2002; Edbauer et al., 2003). g-Secretase cleaves
a variety of substrates within the hydrophobic bilayer of
cellular membranes and is a key player in the generation of
the neurotoxic Amyloid b-peptide (Ab) found in neuritic
plaques of Alzheimer’s disease (AD) patients (Haass and
Selkoe, 2007). Ab is generated via regulated intramembrane
proteolysis (RIP) from the b-Amyloid Precursor Protein
(APP). During amyloidogenic processing APP first under-
goes shedding by the b-site APP cleaving enzyme (BACE),
releasing a large part of the APP ectodomain and generating
a membrane bound C-terminal stub (APP CTF). In a second
proteolytic step the APP CTF is a substrate for intramem-
brane cleavage by g-secretase releasing the APP intracellular
domain (AICD) into the cytosol and Ab into the extracellular
space (Steiner et al., 2008). The active center of the g-secre-
tase complex is composed of either Presenilin (PS) 1 or PS2
(De Strooper et al., 1998; Steiner et al., 1999; Wolfe et al.,
1999; Herreman et al., 2000; Zhang et al., 2000). PSs are
nine-transmembrane proteins and belong to the GxGD-type
intramembrane aspartyl proteases (Steiner et al., 2008), as
one of their critical active site aspartate residues is located
within a conserved GxGD-motif in transmembrane domain
(TMD) 7 (Steiner et al., 2000). In addition to Nicastrin and
PS two other integral membrane proteins, Aph-1 (Aph-1a or
Aph-1b) and Pen-2 (Goutte et al., 2000; Francis et al., 2002),
are essential to form a stable and catalytically active g-secre-
tase complex (Lee et al., 2002; Steiner et al., 2002; Edbauer
et al., 2003; Kimberly et al., 2003; Takasugi et al., 2003).
The mature g-secretase is a stable complex with a half-life
time of more than 24 h in mammalian cells (Ratovitski
et al., 1997). During the assembly of the g-secretase complex
in the endoplasmic reticulum (ER) Nicastrin and Aph-1 form
a premature subcomplex, which then recruits and stabilizes
PS (LaVoie et al., 2003; Takasugi et al., 2003; Shirotani
et al., 2004). Upon incorporation of Pen-2, PS is autoproteo-
lytically cleaved within its large cytosolic loop between
TMD 6 and 7 resulting in an N- and a C-terminal fragment,
which remain tightly associated within the mature g-secre-
tase complex (Thinakaran et al., 1996; Capell et al., 1998;
Yu et al., 2001; Takasugi et al., 2003; Prokop et al., 2004;
Fukumori et al., 2010). After its complete assembly the g-
secretase complex is exported to later secretory compart-
ments where Nicastrin undergoes complex glycosylation
(Kaether et al., 2002). Nicastrin maturation in mammalian
cells is dependent on the correct binding of Nicastrin to the
other complex components (Edbauer et al., 2002; Kimberly
et al., 2002; Leem et al., 2002; Tomita et al., 2002; Yang
et al., 2002). Interestingly, complex glycosylation of Nicas-
trin in later secretory compartments is not necessarily
required for g-secretase activity or cell surface transport of
the complex (Herreman et al., 2003; Shirotani et al., 2003).
On the other hand, core glycosylation and folding of Nicas-
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trin in the ER seems to be the critical step determining sta-
bility and activity of the g-secretase complex (Hayashi et al.,
2009). Using multiple sequence alignment analysis, it has
been shown that the Nicastrin ectodomain shares some
homology with the aminopeptidase and transferrin receptor
family. In particular, Streptomyces griseus aminopeptidase
(SGAP) and the human transferrin receptor (TfR) ectodo-
main exhibit substantial homology with large parts of the
Nicastrin ectodomain (Fagan et al., 2001). SGAP is a zinc-
metalloprotease, which is characterized by a high thermal
stability of up to 708C–808C (Vosbeck et al., 1973). The
human TfR is a type II transmembrane glycoprotein, which
mediates the cellular uptake of iron by binding to and endo-
cytosis of the serum iron transport protein transferrin (Rich-
ardson and Ponka, 1997). Like SGAP, the secondary
structure of TfR exhibits an enhanced stability against ther-
mal denaturation (Orberger et al., 2001). Due to its homology
to the aminopeptidase superfamily, it was suggested that
Nicastrin may serve as a substrate receptor. It was shown
that Glu333 of the Nicastrin ectodomain binds to the N-ter-
mini of type I transmembrane proteins, which were truncated
by the initial shedding step and serve as the immediate sub-
strates for g-secretase (Shah et al., 2005; Dries et al., 2009).
However, these findings have been recently challenged
(Chavez-Gutierrez et al., 2008; Martin et al., 2009) and it
was suggested that the Nicastrin protein instead plays a crit-
ical role in stabilizing the g-secretase complex (Zhang et al.,
2005, 2010).
To provide further evidence that Nicastrin may share evo-
lutionary conserved properties with the aminopeptidase/
transferrin receptor superfamily we investigated whether the
Nicastrin ectodomain is able to adopt a characteristic and
stable secondary structure with similar biophysical properties
like its proposed homologues.
Results
The Nicastrin ectodomain adopts a defined
secondary structure
In order to determine the structural properties and the sta-
bility of the Nicastrin ectodomain (ectoNicastrin) we
expressed a Nicastrin IgG fusion protein (Figure 1A), con-
taining the entire ectoNicastrin (amino acids 1–669) includ-
ing the native N-terminal ER targeting signal sequence in
HEK293 cells. Cell lysates of HEK293 cells expressing the
Nicastrin IgG fusion protein predominantly contain the
immature variant of the fusion protein, while the mature form
is secreted efficiently into the culture medium (Figure 1B).
To ensure that Nicastrin IgG undergoes complex glycosyla-
tion similar to that of native Nicastrin, lysates and condi-
tioned media from cells expressing endogenous Nicastrin or
additionally Nicastrin IgG were treated with Endoglycosi-
dase H (EndoH) to selectively remove non-complex sugars.
The immature Nicastrin IgG found in the cell lysates was
sensitive to treatment with EndoH whereas the secreted ver-
sion of the fusion protein was partially resistant like the
mature form of native Nicastrin w(Edbauer et al., 2002; Shi-
rotani et al., 2003) and Figure 1Bx. This confirms that the
Nicastrin IgG fusion protein is correctly translated into the
ER and undergoes complex N-glycosylation similar to endo-
genous Nicastrin. After demonstrating physiological matu-
ration of Nicastrin IgG we purified the fusion protein via
affinity binding to a protein A column and selectively cleaved
off ectoNicastrin using Faktor Xa (Figure 1C). Factor Xa was
subsequently removed using benzamidine and ectoNicastrin
was further purified by size exclusion chromatography
(Figure 1C). Silver staining of the respective fractions dem-
onstrates the purity of the individual fractions (Figure 1C).
To investigate whether ectoNicastrin adopts a defined sec-
ondary structure we performed Circular Dichroism (CD)
spectroscopy. As indicated by the minima of the ellipticity
at 210 nm and 222 nm and the maximum at 195 nm ecto-
Nicastrin is predominantly in an a-helical conformation at
208C (Figure 1D). This result demonstrates that recombinant
Nicastrin adopts a highly structured secondary conformation.
The secondary structure of the Nicastrin
ectodomain is highly thermostable
To elucidate whether ectoNicastrin exhibits a characteristic
thermostability like its potential relatives SGAP (Vosbeck
et al., 1973) and TfR (Orberger et al., 2001) CD spectra were
collected after stepwise heating (Figure 2). EctoNicastrin was
indeed particularly stable. Upon heating only little unfolding
was observed whereas the majority of ectoNicastrin
remained in its predominantly a-helical conformation up to
858C (Figure 2A). Similar findings were made for the
unfolding process of SGAP. SGAP lost only little of its a-
helical conformation up to 758C (Figure 2B), which is con-
sistent with previously published data (Vosbeck et al., 1973).
A structural switch occurred only at temperatures above
858C or 758C for ectoNicastrin or SGAP, respectively, as
indicated by a shift of the CD minimum towards 200 nm
and the increase in CD at 222 nm (Figure 2A and B). At
temperatures )908C SGAP started to aggregate and precip-
itated (data not shown). In the temperature range from 208C
up to 758C the CD spectra of ectoNicastrin show an isodi-
chroic point at 204 nm suggesting that there is a two state
equilibrium between unfolded and folded states of the pro-
tein. In contrast, SGAP seems to undergo a gradual transition
into an irreversibly denatured state, although the bulk of the
protein remains folded up to 75oC. Taken together these data
suggest that the Nicastrin ectodomain acquires a highly
thermostable secondary structure similar to its homologues
of the aminopeptidase superfamily.
The Nicastrin ectodomain refolds efficiently after
thermal denaturation
Since ectoNicastrin turned out to be extremely stable during
heating, we next investigated its refolding properties. After
heating to 1008C the sample containing ectoNicastrin was
cooled to 208C. CD spectra were collected prior to heating,
at 1008C and after cooling (Figure 3A). The two spectra
acquired prior to heating and after cooling were highly sim-
ilar and no shift of the characteristic minima was observed,
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Figure 1 The Nicastrin ectodomain adopts a defined secondary structure.
(A) Model depicting the Nicastrin IgG fusion protein. The Nicastrin ectodomain is shown in blue, the IgG fusion in red and the Nicastrin
signal sequence is highlighted in yellow. Black boxes indicate the conserved regions including the DYIGS (amino acid 336–340) motif and
potential glycosylation sites are marked by black circles. Glu 333, which was reported to be involved in g-secretase substrate recognition
(Shah et al., 2005) is marked by an asterisk. (B) Endo H resistance of Nicastrin IgG. Immunoprecipitated endogenous Nicastrin and Nicastrin
IgG were incubated in the presence or absence of EndoH. Nicastrin variants were detected with a polyclonal antibody directed against the
N-terminus of Nicastrin. (C) Purification of ectoNicastrin. Starting material: Conditioned media from HEK293 cells, expressing the Nicastrin
IgG fusion protein were separated using SDS polyacrylamid gel electrophoresis and stained with coomassie blue. Factor Xa cleavage: The
starting material was applied to a Protein A column. Upon factor Xa cleavage ectoNicastrin was eluted and factor Xa was removed using
a benzamidine. The eluate was separated on SDS polyacrylamid gel electrophoresis and silver-stained. Gel filtration: The concentrated
benzamidine eluate was applied to a Superdex 200 HR 30/10 gel filtration column and a silver stain of the fraction used for CD spectroscopy
was performed. The asterisk indicates bovine serum albumin (BSA) from the conditioned media. (D) CD sprectroscopy of ectoNicastrin:
The CD spectrum of ectoNicastrin was recorded at 20oC. Note that ectoNicastrin adopts a predominantly a-helical structure as indicated
by the minima of the ellipticity (Q) at 210 nm and 222 nm and the maximum at 195 nm.
while the spectrum collected at 1008C showed a significant
change in secondary structure (Figure 3A). In contrast SGAP
did not regain its original structure after thermal denatura-
tion, but rather remained in an unfolded conformation
(Figure 3B). This suggests that ectoNicastrin, in contrast to
SGAP, has the ability to almost completely refold to its
original conformation after thermal unfolding. Taken togeth-
er these data indicate that the Nicastrin ectodomain adopts a
highly stable structure, which remains refoldable even upon
denaturation.
A N-terminal deletion of Nicastrin reduces
thermostability and the capacity of refolding
We previously demonstrated, that deletions in the Nicastrin
ectodomain abolish the incorporation of Nicastrin into the
g-secretase complex (Shirotani et al., 2003). To investigate
whether such a deletion also influences the thermostability
and the refolding capacity of the Nicastrin ectodomain, we
expressed a Nicastrin IgG fusion protein, which lacks amino
acid 40–164 of the Nicastrin ectodomain (Nicastrin IgG
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Figure 2 The ectoNicastrin secondary structure is stable up to
85oC.
CD spectra of ectoNicastrin (A) or SGAP (B) were recorded at
increasing temperatures as indicated. Both ectoNicastrin and SGAP
did not significantly change their secondary structures at tempera-
tures up to 858C or 75oC, respectively. In contrast to ectoNicastrin,
which undergoes a significant structural change at temperatures
)85oC, SGAP started to unfold at temperatures )758C and aggre-
gated at temperatures )90oC.
Figure 3 The ectoNicastrin refolds efficiently upon heat
denaturation.
(A) The CD spectra of ectoNicastrin or (B) SGAP prior to heating
were recorded at 208C as described in Figure 1D (black line). The
proteins were subsequently heated to 1008C (ectoNicastrin) or 908C
(SGAP; blue line) and cooled again followed by the recording of a
third CD spectrum at 208C (red line). For ectoNicastrin only a minor
difference between the two spectra prior to heating and after cooling
was observed, indicating that ectoNicastrin almost completely
refolded after thermal unfolding. In contrast SGAP was not capable
of refolding after thermal denaturation.
D40–164) (Figure 4A). The fusion protein was purified
analogous to ectoNicastrin and the refolding capacity was
determined. Compared to ectoNicastrin (Figure 3A) the re-
folding capacity of ectoNicastrin D40–164 was reduced, since
the characteristic minima for an a-helical conformation were
not fully regained after sample cooling (Figure 4B). These
data suggest that deletions in the ectodomain of Nicastrin
might affect the thermal properties of its secondary structure.
Discussion
Here we demonstrate a surprising thermostability and refold-
ing capacity of the recombinant Nicastrin ectodomain. This
is particularly interesting since other members of the amino-
peptidase family such as SGAP, which share substantial
homologies with the Nicastrin ectodomain (Fagan et al.,
2001) show similar properties (Vosbeck et al., 1973; Orberger
et al., 2001).
Remarkably the thermostability and the capability of refold-
ing of the Nicastrin ectodomain is even more pronounced
than that of SGAP. Since recently it has been proposed, that
the thermodynamic stabilization of a protein might correlate
with its degree of glycosylation (Shental-Bechor and Levy,
2008), the complex glycosylation pattern within the Nicastrin
ectodomain may contribute to its extraordinary thermosta-
bility. The finding that a mutant variant of Nicastrin
(Nicastrin D40–164) that lacks at least two glycosylation
sites in the N-terminal domain shows a slightly reduced ther-
mostability and refolding capacity, may further support this
hypothesis. This idea may be additionally supported by the
observation that interference with early glycosylation events
in the ER causes inappropriate glycosylation of Nicastrin
leading to a destabilization of the g-secretase complex and
a reduced intrinsic activity (Hayashi et al., 2009), while
blocking later steps in the N-glycosylation pathway still
retains g-secretase activity (Herreman et al., 2003; Shirotani
et al., 2003). However, deletions and mutations could also
affect secondary structure, thermostability and function inde-
pendent of the glycosylation pattern. To finally prove the
hypothesis that the degree of glycosylation within the Nicas-
trin ectodomain, which is determined in the ER, is respon-
sible for stability and integrity of the g-secretase complex,
rather than the size of the polysaccharide side chains, Nicas-
trin mutants, which lack defined N-glycosylation sites,
should be investigated.
Although ectoNicastrin D40–164, according to the CD
spectrum at 20oC, seems to adopt a similar structure like
ectoNicastrin this mutant variant is non-functional in a cell
culture system (Shirotani et al., 2003). This suggests that
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Figure 4 Reduced refolding propensities of ectoNicastrin
D40–164.
(A) Model depicting the Nicastrin IgG D40–164 fusion protein,
which lacks amino acid 40–164 of the Nicastrin ectodomain. The
mutated Nicastrin ectodomain is shown in blue, the IgG fusion in
red and the Nicastrin signal sequence is highlighted in yellow. Black
boxes indicate the conserved regions including the DYIGS (amino
acid 336–340) motif and potential glycosylation sites are marked
by black circles. Glu 333, which was reported to be involved in g-
secretase substrate recognition (Shah et al., 2005) is marked by an
asterisk. (B) CD spectra of ectoNicastrin D40–164 prior to heating
(black line), at 1008C (blue line) and after heating (red line) were
recorded as described in Figure 3A. Note that in contrast to
ectoNicastrin (Figure 3A) the refolding capacity of ectoNicastrin
D40–164 is impaired, since the minima of the ellipticity (Q) char-
acteristic for an a-helical conformation after heating are less pro-
nounced than before heat denaturation.
already small changes in the secondary structure of Nicastrin
are sufficient to affect the proper function of the g-secretase
complex.
Taken together, although Nicastrin lacks an aminopepti-
dase activity, it shows a similar extraordinary and even fur-
ther improved highly thermostable secondary structure like
its homologs. Whether these findings prove the hypothesis,
that Nicastrin evolved from the aminopeptidase and trans-
ferrin receptor family remains, however, to be shown.
Materials and methods
Cell culture, cDNAs and transfection
HEK293EBNA cells were cultured in DMEM with Glutamax (Invi-
trogen GmbH, Karlsruhe, Germany) supplemented with 10% fetal
calf serum (Invitrogen GmbH), and 1% Penicillin/Streptomycin
(Invitrogen GmbH). Using PCR the Nicastrin ectodomain (amino
acid 1–669; amino acid numbering according to Yu et al. (2000);
GenBank: AAG11412.1) or the Nicastrin ectodomain carrying a
deletion from amino acid 40–164 (D40–164; amino acid numbering
according to Yu et al. (2000); GenBank: AAG11412.1) was fused
to the human IgG1 hinge-CH3 heavy chain. Between the two genes
a spacer of 27 basepairs containing a Factor Xa cleavage site was
included. The fusion construct was subcloned into the NheI and
NotI sites of pcDNA 3.1. Zeo – (Invitrogen GmbH), sequence ver-
ified and stably transfected into HEK293EBNA cells. Transfection
of cells was carried out using Lipofectamine 2000 (Invitrogen
GmbH) according to the manufacturer’s instructions and single cell
clones were generated by selection in 200 mg/ml zeocine (Invitro-
gen GmbH).
Purification of the Nicastrin ectodomain
(ectoNicastrin)
Cells described above were cultured in TripleFlasks NunclonD
Surface (Thermo Fisher Scientific, Roskilde, Denmark), conditioned
medium was collected and filtered using Bottle Top Filter 0.22 mM
(Milipore GmbH, Schwalbach/Ts., Germany) to remove remaining
cellular particles. To purify aproximatly 0.5 mg of the Nicastrin
ectodomain 5 l conditioned medium were collected. The conditioned
medium was directly applied to a Protein A column (GE Healthcare-
Bio Science, Uppsala, Sweden) using an A¨ KTA purifier (GE
Healthcare-Bio Science) supplied with a separate sample pump
(Direkt Load 960; DE Healthcare-Bio Science). After washing with
100 ml buffer A (50 mM Tris, pH 7.4), 6 ml Factor Xa solution
w(20 mM Tris, 100 mM NaCl, 2 mM CaCl2, pH 8.0 supplemented
with 20 mg/ml Factor Xa (New England Biolabs, Ipswich MA,
USA)x were added manually to the column and the column was
incubated for roughly 16 h at 8oC. To remove factor Xa, the eluate
form the Protein A column containing the cleaved Nicastrin ecto-
domain was directly applied to a benzamidine column (GE Health-
care-Bio Science) using 50 ml buffer B (50 mM Tris, 500 mM NaCl,
pH 7.4). The eluate from the benzamidine column was fractionated
and the fractions containing the ectoNicastrin were pooled and con-
centrated to 1/4 of the original volume using a Viva Spin column
50.000 MWCO (SartoriusStedim Biotech, Go¨ttingen, Germany)
according to the manufacturer’s instructions. Finally the sample was
applied to a Superdex 200 HR 30/10 gel filtration column (GE
Healthcare-Bio Science) and separated using buffer C (20 mM sodi-
um phosphate buffer, pH 7.2, supplemented with 100 mM KCl).
Deglycosylation experiments
For deglycosylation cells were lysed in STEN buffer (50 mM Tris,
pH 7.6, 150 mM NaCl, 2 mM EDTA) supplemented with 1% Noni-
det P-40 (NP-40), 1% Triton X-100 and 2% bovine serum albumin
(BSA) on ice for 20 min. Lysates were clarified by centrifugation
for 45 min at 100 000 g and 48C. Endogenous Nicastrin was immu-
noprecipitated using the polyclonal antibody N1660 (Sigma-
Aldrich, St. Louis, MO, USA) against the C-terminus of Nicastrin.
Nicastrin IgG was immunoprecipitated using Protein A coupled
sepharose beads (Sigma-Aldrich). Precipitates were incubated in the
presence of 50 mU/ml endoglycosidase H (endo H; Roche Diag-
nostics GmbH, Mannheim, Germany) for 14 h at 378C in the appro-
priate buffer. Reactions were stopped by the addition of SDS sample
buffer and reaction mixtures were separated by SDS-polyacrylamid
gel electrophoresis. For Nicastrin detection the polyclonal antibody
against the N-terminus of Nicastrin (NCT-NT, 1658) was used
(Capell et al., 2003).
Circular Dichroism (CD) spectroscopy
Proteins were dissolved in buffer C (see above) at a concentration
of approximately 1 mg/ml and diluted to 0.1 mg/ml with water.
Aminopeptidase I from Strepomyces griseus (SGAP) was obtained
from Sigma-Aldrich (Product Number A9934). CD spectra were
measured with a Jasco J-810 Spectropolarimeter (Jasco, Inc., Easton
MD, USA) using a cuvette with a path length of 0.2 cm. Spectra
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of 10 scans were averaged. Temperature in the measuring cell was
gradually increased as indicated in the respective figures, and at
defined temperature intervals CD spectra were taken from
300–190 nm. Temperature control with an accuracy of 0.58C in the
cuvette was achieved with a heating/cooling accessory using a Pel-
tier element. CD data are expressed as the mean residue ellipticity
(Q) in deg cm2 dmol-1 at the respective wave length in nm. The
mean residue ellipticity was calculated from the measured ellipticity
(u, in mdeg) by dividing the molar ellipticity (u=100/(wProteinx=d),
d is the cuvette path length in cm) by the amount of residues (N)
of the corresponding protein (Ns675 for EctoNicastrin; Ns550 for
EctoNicastrin D40–164; Ns284 for SGAP). The molecular weights
of EctoNicastrin and EctoNicastrin D40–164 were 75 kDa and
61 kDa, respectively. The molecular weight of SGAP was 30 kDa.
Acknowledgements
This work was supported by the Leibniz Award of Deutsche For-
schungsgemeinschaft (DFG; to C.H.), the Collaborative Research
Center Molecular Mechanisms of Neurodegeneration (SFB 596;
C.H., H.S.), the DFG grant HA1737-11-1 and HA1737-11-2 to C.H.
and R.F. and the Center for Integrated Protein Science Munich. C.H.
is supported by a Research Professorship provided by the
LMUexcellent program. We thank Dr. Jasmin Sydow for helpful dis-
cussion, Martina Haug-Kro¨per and Ba¨rbel Klier for excellent tech-
nical assistance. The cDNAs for the Nicastrin deletion construct and
the human IgG heavy chain were kindly provided by Drs. Keiro
Shirotani and Ju¨rgen Haas, respectively.
References
Capell, A., Grunberg, J., Pesold, B., Diehlmann, A., Citron, M.,
Nixon, R., Beyreuther, K., Selkoe, D.J., and Haass, C. (1998).
The proteolytic fragments of the Alzheimer’s disease-associated
presenilin-1 form heterodimers and occur as a 100–150-kDa
molecular mass complex. J. Biol. Chem. 273, 3205–3211.
Capell, A., Kaether, C., Edbauer, D., Shirotani, K., Merkl, S., Steiner,
H., and Haass, C. (2003). Nicastrin interacts with g-secretase
complex components via the N-terminal part of its transmem-
brane domain. J. Biol. Chem. 278, 52519–52523.
Chavez-Gutierrez, L., Tolia, A., Maes, E., Li, T., Wong, P.C., and
de Strooper, B. (2008). Glu(332) in the Nicastrin ectodomain is
essential for g-secretase complex maturation but not for its activ-
ity. J. Biol. Chem. 283, 20096–20105.
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H.,
Guhde, G., Annaert, W., Von Figura, K., and Van Leuven, F.
(1998). Deficiency of presenilin-1 inhibits the normal cleavage
of amyloid precursor protein. Nature 391, 387–390.
Dries, D.R., Shah, S., Han, Y.H., Yu, C., Yu, S., Shearman, M.S.,
and Yu, G. (2009). Glu-333 of nicastrin directly participates in
g-secretase activity. J. Biol. Chem. 284, 29714–29724.
Edbauer, D., Winkler, E., Haass, C., and Steiner, H. (2002). Prese-
nilin and nicastrin regulate each other and determine amyloid b-
peptide production via complex formation. Proc. Natl. Acad. Sci.
USA 99, 8666–8671.
Edbauer, D., Winkler, E., Regula, J.T., Pesold, B., Steiner, H., and
Haass, C. (2003). Reconstitution of g-secretase activity. Nat.
Cell Biol. 5, 486–488.
Fagan, R., Swindells, M., Overington, J., and Weir, M. (2001).
Nicastrin, a presenilin-interacting protein, contains an amino-
peptidase/transferrin receptor superfamily domain. Trends Bio-
chem. Sci. 26, 213–214.
Francis, R., McGrath, G., Zhang, J., Ruddy, D.A., Sym, M., Apfeld,
J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., et al. (2002).
Aph-1 and pen-2 are required for Notch pathway signaling, g-
secretase cleavage of bAPP, and presenilin protein accumulation.
Dev. Cell 3, 85–97.
Fukumori, A., Fluhrer, R., Steiner, H., and Haass, C. (2010). Three-
amino acid spacing of presenilin endoproteolysis suggests a gen-
eral stepwise cleavage of g-secretase-mediated intramembrane
proteolysis. J. Neurosci. 30, 7853–7862.
Goutte, C., Hepler, W., Mickey, K.M., and Priess, J.R. (2000).
Aph-2 encodes a novel extracellular protein required for GLP-
1-mediated signaling. Development 127, 2481–2492.
Haass, C. and Selkoe, D.J. (2007). Soluble protein oligomers in
neurodegeneration: lessons from the Alzheimer’s amyloid
b-peptide. Nat. Rev. Mol. Cell Biol. 8, 101–112.
Hayashi, I., Takatori, S., Urano, Y., Iwanari, H., Isoo, N., Osawa,
S., Fukuda, M.A., Kodama, T., Hamakubo, T., Li, T., et al.
(2009). Single chain variable fragment against nicastrin inhibits
the g-secretase activity. J. Biol. Chem. 284, 27838–27847.
Herreman, A., Serneels, L., Annaert, W., Collen, D., Schoonjans,
L., and De Strooper, B. (2000). Total inactivation of g-secretase
activity in presenilin-deficient embryonic stem cells. Nat. Cell
Biol. 2, 461–462.
Herreman, A., Van Gassen, G., Bentahir, M., Nyabi, O., Craessaerts,
K., Mueller, U., Annaert, W., and De Strooper, B. (2003). g-
Secretase activity requires the presenilin-dependent trafficking
of nicastrin through the Golgi apparatus but not its complex
glycosylation. J. Cell Sci. 116, 1127–1136.
Kaether, C., Lammich, S., Edbauer, D., Ertl, M., Rietdorf, J., Capell,
A., Steiner, H., and Haass, C. (2002). Presenilin-1 affects traf-
ficking and processing of b-APP and is targeted in a complex
with nicastrin to the plasma membrane. J. Cell Biol. 158,
551–561.
Kimberly, W.T., LaVoie, M.J., Ostaszewski, B.L., Ye, W., Wolfe,
M.S., and Selkoe, D.J. (2002). Complex N-linked glycosylated
nicastrin associates with active g-secretase and undergoes tight
cellular regulation. J. Biol. Chem. 277, 35113–35117.
Kimberly, W.T., LaVoie, M.J., Ostaszewski, B.L., Ye, W., Wolfe,
M.S., and Selkoe, D.J. (2003). g-Secretase is a membrane pro-
tein complex comprised of presenilin, nicastrin, Aph-1, and Pen-
2. Proc. Natl. Acad. Sci. USA 100, 6382–6387.
LaVoie, M.J., Fraering, P.C., Ostaszewski, B.L., Ye, W., Kimberly,
W.T., Wolfe, M.S., and Selkoe, D.J. (2003). Assembly of the
g-secretase complex involves early formation of an intermediate
subcomplex of Aph-1 and nicastrin. J. Biol. Chem. 278,
37213–37222.
Lee, S.F., Shah, S., Li, H., Yu, C., Han, W., and Yu, G. (2002).
Mammalian APH-1 interacts with presenilin and nicastrin and is
required for intramembrane proteolysis of amyloid-b precursor
protein and Notch. J. Biol. Chem. 277, 45013–45019.
Leem, J.Y., Vijayan, S., Han, P., Cai, D., Machura, M., Lopes, K.O.,
Veselits, M.L., Xu, H., and Thinakaran, G. (2002). Presenilin 1
is required for maturation and cell surface accumulation of nicas-
trin. J. Biol. Chem. 277, 19236–19240.
Martin, L., Fluhrer, R., and Haass, C. (2009). Substrate requirements
for SPPL2b-dependent regulated intramembrane proteolysis.
J. Biol. Chem. 284, 5662–5670.
Orberger, G., Fuchs, H., Geyer, R., Gessner, R., Kottgen, E., and
Tauber, R. (2001). Structural and functional stability of the
mature transferrin receptor from human placenta. Arch.
Biochem. Biophys. 386, 79–88.
Prokop, S., Shirotani, K., Edbauer, D., Haass, C., and Steiner, H.
(2004). Requirement of PEN-2 for stabilization of the presenilin
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 31.10.13 15:45
Thermostability of the Nicastrin ectodomain 1001
Article in press - uncorrected proof
N-/C-terminal fragment heterodimer within the g-secretase com-
plex. J. Biol. Chem. 279, 23255–23261.
Ratovitski, T., Slunt, H.H., Thinakaran, G., Price, D.L., Sisodia,
S.S., and Borchelt, D.R. (1997). Endoproteolytic processing and
stabilization of wild-type and mutant presenilin. J. Biol. Chem.
272, 24536–24541.
Richardson, D.R. and Ponka, P. (1997). The molecular mechanisms
of the metabolism and transport of iron in normal and neoplastic
cells. Biochim. Biophys. Acta 1331, 1–40.
Shah, S., Lee, S.F., Tabuchi, K., Hao, Y.H., Yu, C., LaPlant, Q.,
Ball, H., Dann, C.E., 3rd, Sudhof, T., and Yu, G. (2005). Nicas-
trin functions as a g-secretase-substrate receptor. Cell 122,
435–447.
Shental-Bechor, D. and Levy, Y. (2008). Effect of glycosylation on
protein folding: a close look at thermodynamic stabilization.
Proc. Natl. Acad. Sci. USA 105, 8256–8261.
Shirotani, K., Edbauer, D., Capell, A., Schmitz, J., Steiner, H., and
Haass, C. (2003). g-Secretase activity is associated with a con-
formational change of nicastrin. J. Biol. Chem. 278, 16474–
16477.
Shirotani, K., Edbauer, D., Kostka, M., Steiner, H., and Haass, C.
(2004). Immature nicastrin stabilizes APH-1 independent of
PEN-2 and presenilin: identification of nicastrin mutants that
selectively interact with APH-1. J. Neurochem. 89, 1520–1527.
Steiner, H., Duff, K., Capell, A., Romig, H., Grim, M.G., Lincoln,
S., Hardy, J., Yu, X., Picciano, M., Fechteler, K., et al. (1999).
A loss of function mutation of presenilin-2 interferes with amy-
loid b-peptide production and Notch signaling. J. Biol. Chem.
274, 28669–28673.
Steiner, H., Kostka, M., Romig, H., Basset, G., Pesold, B., Hardy,
J., Capell, A., Meyn, L., Grim, M.G., Baumeister, R., et al.
(2000). Glycine 384 is required for presenilin-1 function and is
conserved in polytopic bacterial aspartyl proteases. Nat. Cell
Biol. 2, 848–851.
Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yama-
saki, A., Kostka, M., and Haass, C. (2002). PEN-2 is an integral
component of the g-secretase complex required for coordinated
expression of presenilin and nicastrin. J. Biol. Chem. 277,
39062–39065.
Steiner, H., Fluhrer, R., and Haass, C. (2008). Intramembrane pro-
teolysis by g-secretase. J. Biol. Chem. 283, 29627–29631.
Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M.,
Takahashi, Y., Thinakaran, G., and Iwatsubo, T. (2003). The role
of presenilin cofactors in the g-secretase complex. Nature 422,
438–441.
Thinakaran, G., Borchelt, D.R., Lee, M.K., Slunt, H.H., Spitzer, L.,
Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger,
M., et al. (1996). Endoproteolysis of presenilin 1 and accumu-
lation of processed derivatives in vivo. Neuron 17, 181–190.
Tomita, T., Katayama, R., Takikawa, R., and Iwatsubo, T. (2002).
Complex N-glycosylated form of nicastrin is stabilized and
selectively bound to presenilin fragments. FEBS Lett. 520,
117–121.
Vosbeck, K.D., Chow, K.F., and Awad, W.M., Jr. (1973). The pro-
teolytic enzymes of the K-1 strain of Streptomyces griseus
obtained from a commercial preparation (Pronase). Purification
and characterization of the aminopeptidases. J. Biol. Chem. 248,
6029–6034.
Wolfe, M.S., Xia, W., Ostaszewski, B.L., Diehl, T.S., Kimberly,
W.T., and Selkoe, D.J. (1999). Two transmembrane aspartates in
presenilin-1 required for presenilin endoproteolysis and g-secre-
tase activity. Nature 398, 513–517.
Yang, D.S., Tandon, A., Chen, F., Yu, G., Yu, H., Arawaka, S.,
Hasegawa, H., Duthie, M., Schmidt, S.D., Ramabhadran, T.V.,
et al. (2002). Mature glycosylation and trafficking of nicastrin
modulate its binding to presenilins. J. Biol. Chem. 277, 28135–
28142.
Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon,
A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., et al. (2000).
Nicastrin modulates presenilin-mediated notch/glp-1 signal
transduction and bAPP processing. Nature 407, 48–54.
Yu, C., Kim, S.H., Ikeuchi, T., Xu, H., Gasparini, L., Wang, R., and
Sisodia, S.S. (2001). Characterization of a presenilin-mediated
APP carboxyl terminal fragment CTFg: evidence for distinct
mechanisms involved in g-secretase processing of the APP and
Notch1 transmembrane domains. J. Biol. Chem. 276, 43756–
43760.
Zhang, Z., Nadeau, P., Song, W., Donoviel, D., Yuan, M., Bernstein,
A., and Yankner, B.A. (2000). Presenilins are required for g-
secretase cleavage of bAPP and transmembrane cleavage of
Notch-1. Nat. Cell Biol. 2, 463–465.
Zhang, Y.W., Luo, W.J., Wang, H., Lin, P., Vetrivel, K.S., Liao, F.,
Li, F., Wong, P.C., Farquhar, M.G., Thinakaran, G., et al. (2005).
Nicastrin is critical for stability and trafficking but not associa-
tion of other presenilin/g-secretase components. J. Biol. Chem.
280, 17020–17026.
Zhao, G., Liu, Z., Ilagan, M.X., and Kopan, R. (2010). g-secretase
composed of PS1/Pen2/Aph1a can cleave notch and amyloid
precursor protein in the absence of nicastrin. J. Neurosci. 30,
1648–1656.
Received May 30, 2011; accepted August 4, 2011
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 31.10.13 15:45
